Search Results

There are 27716 results for: content related to: Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C

  1. You have free access to this content
    Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study


    Volume 56, Issue 3, September 2012, Pages: 884–893, Michael P. Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau-Ting Yeh, Patrick Marcellin, Richard T. Wiedmann, Peggy M. Hwang, Luzelena Caro, Richard J.O. Barnard, Andrew W. Lee and for the MK-7009 Protocol 007 Study Group

    Version of Record online : 17 JUL 2012, DOI: 10.1002/hep.25743

  2. You have free access to this content
    Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α

    Clinical Microbiology and Infection

    Volume 18, Issue 10, October 2012, Pages: 1033–1039, C. Scagnolari, S. Trombetti, A. Soldà, M. Milella, G. B. Gaeta, G. Angarano, G. Scotto, N. Caporaso, F. Morisco, R. Cozzolongo, G. Giannelli, M. Fasano, T. Santantonio and G. Antonelli

    Version of Record online : 22 DEC 2011, DOI: 10.1111/j.1469-0691.2011.03729.x

  3. Detection of interferon-alpha expression by PCR in patients with chronic hepatitis C and hepatitis non-A, non-B

    Journal of Gastroenterology and Hepatology

    Volume 9, Issue 4, August 1994, Pages: 373–380, EVELYN R. BRANDT, RODNEY J. DEVENISH, PAUL J. HERTZOG, FRANCIS J. DUDLEY and ANTHONY W. LINNANE

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1440-1746.1994.tb01258.x

  4. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  5. Modulation of cisplatin sensitivity and accumulation by interferon α-2A in human squamous carcinoma cell lines

    International Journal of Cancer

    Volume 63, Issue 3, 3 November 1995, Pages: 419–422, Vicram Gupta, Jitesh P. Jani, Erling O. Emerson, Bing H. Xu, Domenic Scalamogna, Hong Xia, Arthur Katoh, Howard A. Zaren and Shivendra V. Singh

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910630320

  6. Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis

    Hepatology Research

    Volume 43, Issue 12, December 2013, Pages: 1255–1263, Abdulrahman A. Aljumah and Mohammad Hassan Murad

    Version of Record online : 4 MAR 2013, DOI: 10.1111/hepr.12084

  7. Human leukocyte interferon alpha: Structure, pharmacology, and therapeutic applications

    Medicinal Research Reviews

    Volume 15, Issue 5, September 1995, Pages: 445–478, G. C. Viscomi, M. Grimaldi, E. Palazzini and S. Silvestri

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610150504

  8. You have free access to this content
    AASLD Abstracts 1606–1960


    Volume 48, Issue S1, October 2008, Pages: 1019A–1187A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22647

  9. Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1

    Hepatology Research

    Volume 44, Issue 4, April 2014, Pages: 410–419, Toshiji Saibara, Nobuyuki Enomoto, Shuichi Kaneko, Kazuaki Chayama, Michio Sata, Michio Imawari, Saburo Onishi and Kiwamu Okita

    Version of Record online : 20 JUN 2013, DOI: 10.1111/hepr.12139

  10. You have free access to this content
    5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules


    Volume 72, Issue 11, 1 December 1993, Pages: 3191–3195, William J. John, John R. Neefe, John S. Macdonald, Jim Cantrell Jr. and Marietta Smith

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19931201)72:11<3191::AID-CNCR2820721110>3.0.CO;2-7

  11. Interferon-alpha plus adefovir combination therapy versus interferon-alpha monotherapy for chronic hepatitis B treatment: A meta-analysis

    Hepatology Research

    Volume 43, Issue 10, October 2013, Pages: 1040–1051, Rui Huang, Yingying Hao, Jun Zhang and Chao Wu

    Version of Record online : 29 JAN 2013, DOI: 10.1111/hepr.12058

  12. The differential effects of three forms of interferon alfa on hepatic regeneration after partial hepatectomy in the rat


    Volume 22, Issue 3, September 1995, Pages: 883–886, Stephen Wong, Tony Gauthier, Kelly D. E. Kaita and Gerald Y. Minuk

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220328

  13. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature

    International Journal of Dermatology

    Volume 50, Issue 3, March 2011, Pages: 287–291, Verónica López, Inmaculada Molina, Carlos Monteagudo and Esperanza Jordá

    Version of Record online : 23 FEB 2011, DOI: 10.1111/j.1365-4632.2010.04728.x

  14. Low-dose pegylated interferon-alpha-2a monotherapy in elderly and/or cirrhotic patients infected with hepatitis C virus genotype-2 or genotype-1 low level infection

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 702–708, Hideyuki Tamai, Kosaku Moribata, Yoshiyuki Mori, Naoki Shingaki, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato and Masao Ichinose

    Version of Record online : 17 DEC 2012, DOI: 10.1111/hepr.12024

  15. Detection of anti-interferon-α2a antibodies in chronic liver disease

    Journal of Gastroenterology and Hepatology

    Volume 4, Issue 5, October 1989, Pages: 411–418, Y. IKEDA, K. MIYAKE, G. TODA, H. YAMADA, M. YAMANAKA and H. OKA

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1440-1746.1989.tb01738.x

  16. The interferon-α2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-α2a

    Journal of Gastroenterology and Hepatology

    Volume 7, Issue 4, August 1992, Pages: 411–416, HITOSHI HOSOI, MITSUNOBU IMAI and MASAMI YAMANAKA

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1440-1746.1992.tb01010.x

  17. 5-fluorouracil and low-dose recombinant interferon-α-2a in patients with hormone-refractory adenocarcinoma of the prostate

    The Prostate

    Volume 35, Issue 1, 1 April 1998, Pages: 56–62, Nobuo Shinohara, Takayoshi Demura, Kin-ya Matsumura, Ken-ichi Toyoda, Akira Kashiwagi, Satoshi Nagamori, Hiroshi Ohmuro, Sei-ichirou Ohzono and Tomohiko Koyanagi

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-0045(19980401)35:1<56::AID-PROS8>3.0.CO;2-F

  18. You have free access to this content
    New HCV therapies on the horizon

    Clinical Microbiology and Infection

    Volume 17, Issue 2, February 2011, Pages: 122–134, J. Vermehren and C. Sarrazin

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1469-0691.2010.03430.x

  19. Interferon therapy for atopic dermatitis reduces basophil histamine release, but does not reduce serum IgE or eosinophilic proteins


    Volume 49, Issue 2, February 1994, Pages: 120–128, B. Windelborg Nielsen, C. M. Reimert, R. Hammer, P.O. Schiøtz and K. Thestrup-Pedersen

    Version of Record online : 28 APR 2007, DOI: 10.1111/j.1398-9995.1994.tb00811.x

  20. Abstract of Papers Submitted to the American Association of the Study of Liver Disease


    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220703